BRAF and neoplasm: In contrast, these associations were not observed in BRAF wild-type patients, regardless of tumor size or laterality.<h4>Conclusions</h4>The current study provides initial evidence that tumor bilaterality serves as a BRAF genotype-dependent prognostic marker, revealing its synergistic effect with BRAF mutation in predicting PTC recurrence.